Peptides associated with HLA-DR MHC class II molecules involved in autoimmune diseases

Details for Australian Patent Application No. 2004216925 (hide)

Owner London Health Sciences Centre Research Inc.

Inventors Hill, Jonathan; Bell, David; Cairns, Ewa

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004216925

PCT Pub. Number WO2004/078098

Priority 60/452,522 07.03.03 US

Filing date 5 March 2004

Wipo publication date 16 September 2004

Acceptance publication date 22 April 2010

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C07K 7/00 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/74 (2006.01) Peptides having more than 20 amino acids

Event Publications

29 September 2005 PCT application entered the National Phase

  PCT publication WO2004/078098 Priority application(s): WO2004/078098

22 April 2010 Application Accepted

  Published as AU-B-2004216925

19 August 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004216926-Electrical needle with radiopaque marker

2004216921-Use of proteolytic enzymes to increase feed utilization in ruminant diets